Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer

Anna G. Sorace, Jason M. Warram, Heidi Umphrey, Kenneth Hoyt

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Background: Ultrasound (US) exposed microbubble (MB) contrast agents have the capability to transiently enhance cell membrane permeability. Using this technique in cancer treatment to increase the efficiency of chemotherapy through passive, localized delivery has been an emerging area of research. Purpose: Investigation of the influence of US parameters on MB-mediated drug delivery in cancer. Methods: The 2LMP breast cancer cells were used for in vitro experiments and 2LMP tumor-bearing mice were used during in vivo experiments. Changes in membrane permeability were investigated after the influence of MB-mediated US therapy parameters (i.e. frequency, mechanical index, pulse repetition period, US duration, and MB dosing and characteristics) on cancer cells. Calcein, a non-permeable fluorescent molecule, and Taxol, chemotherapeutic, were used to evaluate membrane permeability. Tumor response was also assessed histologically. Results: Combination chemotherapy and MB-mediated US therapy with optimized parameters increased cancer cell death by 50% over chemotherapy alone. Discussion: Increased cellular uptake of chemotherapeutic was dependent upon US system parameters. Conclusion: Optimized MB-mediated US therapy has the potential to improve cancer patient response to therapy via increased localized drug uptake, which may lead to a lowering of chemotherapeutic drug dosages and systemic toxicity.

Original languageEnglish (US)
Pages (from-to)43-54
Number of pages12
JournalJournal of Drug Targeting
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Microbubbles
Ultrasonics
Neoplasms
Permeability
Pharmaceutical Preparations
Cell Membrane Permeability
Therapeutics
Drug Therapy
Membranes
Paclitaxel
Combination Drug Therapy
Contrast Media
Cell Death
Breast Neoplasms
Research

Keywords

  • cancer
  • chemotherapy
  • drug delivery
  • microbubble contrast agents
  • Ultrasound

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. / Sorace, Anna G.; Warram, Jason M.; Umphrey, Heidi; Hoyt, Kenneth.

In: Journal of Drug Targeting, Vol. 20, No. 1, 01.01.2012, p. 43-54.

Research output: Contribution to journalArticle

Sorace, Anna G. ; Warram, Jason M. ; Umphrey, Heidi ; Hoyt, Kenneth. / Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. In: Journal of Drug Targeting. 2012 ; Vol. 20, No. 1. pp. 43-54.
@article{97c8209c4cfa405da4b00c63c4b4c6c4,
title = "Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer",
abstract = "Background: Ultrasound (US) exposed microbubble (MB) contrast agents have the capability to transiently enhance cell membrane permeability. Using this technique in cancer treatment to increase the efficiency of chemotherapy through passive, localized delivery has been an emerging area of research. Purpose: Investigation of the influence of US parameters on MB-mediated drug delivery in cancer. Methods: The 2LMP breast cancer cells were used for in vitro experiments and 2LMP tumor-bearing mice were used during in vivo experiments. Changes in membrane permeability were investigated after the influence of MB-mediated US therapy parameters (i.e. frequency, mechanical index, pulse repetition period, US duration, and MB dosing and characteristics) on cancer cells. Calcein, a non-permeable fluorescent molecule, and Taxol, chemotherapeutic, were used to evaluate membrane permeability. Tumor response was also assessed histologically. Results: Combination chemotherapy and MB-mediated US therapy with optimized parameters increased cancer cell death by 50{\%} over chemotherapy alone. Discussion: Increased cellular uptake of chemotherapeutic was dependent upon US system parameters. Conclusion: Optimized MB-mediated US therapy has the potential to improve cancer patient response to therapy via increased localized drug uptake, which may lead to a lowering of chemotherapeutic drug dosages and systemic toxicity.",
keywords = "cancer, chemotherapy, drug delivery, microbubble contrast agents, Ultrasound",
author = "Sorace, {Anna G.} and Warram, {Jason M.} and Heidi Umphrey and Kenneth Hoyt",
year = "2012",
month = "1",
day = "1",
doi = "10.3109/1061186X.2011.622397",
language = "English (US)",
volume = "20",
pages = "43--54",
journal = "Journal of Drug Targeting",
issn = "1061-186X",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer

AU - Sorace, Anna G.

AU - Warram, Jason M.

AU - Umphrey, Heidi

AU - Hoyt, Kenneth

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Background: Ultrasound (US) exposed microbubble (MB) contrast agents have the capability to transiently enhance cell membrane permeability. Using this technique in cancer treatment to increase the efficiency of chemotherapy through passive, localized delivery has been an emerging area of research. Purpose: Investigation of the influence of US parameters on MB-mediated drug delivery in cancer. Methods: The 2LMP breast cancer cells were used for in vitro experiments and 2LMP tumor-bearing mice were used during in vivo experiments. Changes in membrane permeability were investigated after the influence of MB-mediated US therapy parameters (i.e. frequency, mechanical index, pulse repetition period, US duration, and MB dosing and characteristics) on cancer cells. Calcein, a non-permeable fluorescent molecule, and Taxol, chemotherapeutic, were used to evaluate membrane permeability. Tumor response was also assessed histologically. Results: Combination chemotherapy and MB-mediated US therapy with optimized parameters increased cancer cell death by 50% over chemotherapy alone. Discussion: Increased cellular uptake of chemotherapeutic was dependent upon US system parameters. Conclusion: Optimized MB-mediated US therapy has the potential to improve cancer patient response to therapy via increased localized drug uptake, which may lead to a lowering of chemotherapeutic drug dosages and systemic toxicity.

AB - Background: Ultrasound (US) exposed microbubble (MB) contrast agents have the capability to transiently enhance cell membrane permeability. Using this technique in cancer treatment to increase the efficiency of chemotherapy through passive, localized delivery has been an emerging area of research. Purpose: Investigation of the influence of US parameters on MB-mediated drug delivery in cancer. Methods: The 2LMP breast cancer cells were used for in vitro experiments and 2LMP tumor-bearing mice were used during in vivo experiments. Changes in membrane permeability were investigated after the influence of MB-mediated US therapy parameters (i.e. frequency, mechanical index, pulse repetition period, US duration, and MB dosing and characteristics) on cancer cells. Calcein, a non-permeable fluorescent molecule, and Taxol, chemotherapeutic, were used to evaluate membrane permeability. Tumor response was also assessed histologically. Results: Combination chemotherapy and MB-mediated US therapy with optimized parameters increased cancer cell death by 50% over chemotherapy alone. Discussion: Increased cellular uptake of chemotherapeutic was dependent upon US system parameters. Conclusion: Optimized MB-mediated US therapy has the potential to improve cancer patient response to therapy via increased localized drug uptake, which may lead to a lowering of chemotherapeutic drug dosages and systemic toxicity.

KW - cancer

KW - chemotherapy

KW - drug delivery

KW - microbubble contrast agents

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=83155191794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83155191794&partnerID=8YFLogxK

U2 - 10.3109/1061186X.2011.622397

DO - 10.3109/1061186X.2011.622397

M3 - Article

C2 - 21981609

AN - SCOPUS:83155191794

VL - 20

SP - 43

EP - 54

JO - Journal of Drug Targeting

JF - Journal of Drug Targeting

SN - 1061-186X

IS - 1

ER -